[
  {
    "title": "Q1 '24 S&P 500 Earnings (And Johnson & Johnson): Expecting Another Normal Earnings Season",
    "published": 1713213300,
    "posting_price": 108.42634688,
    "close_price": 107.24448395,
    "percent_change": -1.09001453
  },
  {
    "title": "Abbott\u2019s latest Heartmate recall tied to 273 injuries, 14 deaths",
    "published": 1713195778,
    "posting_price": 108.42634688,
    "close_price": 107.24448395,
    "percent_change": -1.09001453
  },
  {
    "title": "Abbott, Thoratec recall HeartMate ventricular systems due to obstruction issue",
    "published": 1713184200,
    "posting_price": 108.42634688,
    "close_price": 107.24448395,
    "percent_change": -1.09001453
  },
  {
    "title": "Netflix and United Airlines to report highest move post earnings: BofA",
    "published": 1713178620,
    "posting_price": 108.42634688,
    "close_price": 107.24448395,
    "percent_change": -1.09001453
  },
  {
    "title": "Abbott Laboratories (ABT)'s Winning Formula: Financial Metrics and Competitive Strengths",
    "published": 1713175440,
    "posting_price": 108.42634688,
    "close_price": 107.24448395,
    "percent_change": -1.09001453
  },
  {
    "title": "Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead",
    "published": 1713174360,
    "posting_price": 108.42634688,
    "close_price": 107.24448395,
    "percent_change": -1.09001453
  },
  {
    "title": "Abbott Laboratories a Top 25 Dividend Giant With 2.02% Yield (ABT)",
    "published": 1713161880,
    "posting_price": 108.42634688,
    "close_price": 107.24448395,
    "percent_change": -1.09001453
  },
  {
    "title": "Options Volatility and Implied Earnings Moves This Week, April 15 \u2013 April 19, 2024",
    "published": 1713160860,
    "posting_price": 108.42634688,
    "close_price": 107.24448395,
    "percent_change": -1.09001453
  },
  {
    "title": "Wall Street Breakfast: The Week Ahead",
    "published": 1713081061,
    "posting_price": 108.42634688,
    "close_price": 107.24448395,
    "percent_change": -1.09001453
  },
  {
    "title": "Earnings week ahead: BAC, JNJ, TSM, UNH, ABT, SLB, UAL, PG, NFLX and more",
    "published": 1713078360,
    "posting_price": 108.42634688,
    "close_price": 107.24448395,
    "percent_change": -1.09001453
  },
  {
    "title": "Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down",
    "published": 1713070860,
    "posting_price": 108.42634688,
    "close_price": 107.24448395,
    "percent_change": -1.09001453
  },
  {
    "title": "Jim Cramer\u2019s 10 Favorite Healthcare Stock Picks in 2024",
    "published": 1713025104,
    "posting_price": 108.42635459,
    "close_price": 107.24449158,
    "percent_change": -1.09001452
  },
  {
    "title": "3 Buy Rated Stocks To Consider As Earnings Approach",
    "published": 1712976240,
    "posting_price": 108.42635459,
    "close_price": 107.24449158,
    "percent_change": -1.09001452
  },
  {
    "title": "What's in Store for Abbott Laboratories (ABT) in Q1 Earnings?",
    "published": 1712929860,
    "posting_price": 108.60362523,
    "close_price": 107.46115875,
    "percent_change": -1.0519598
  },
  {
    "title": "Ahead of Abbott (ABT) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics",
    "published": 1712927723,
    "posting_price": 108.60362523,
    "close_price": 107.46115875,
    "percent_change": -1.0519598
  },
  {
    "title": "Why Wall Street Got Even More Excited About The Glucose Monitor \u2014 And How Dexcom, Abbott Labs Stand To Benefit",
    "published": 1712923236,
    "posting_price": 108.60362523,
    "close_price": 107.46115875,
    "percent_change": -1.0519598
  },
  {
    "title": "Jim Cramer Calls Cummins 'Terrific,' Recommends Selling This Chinese Auto Manufacturer",
    "published": 1712908140,
    "posting_price": 108.60362523,
    "close_price": 107.46115875,
    "percent_change": -1.0519598
  },
  {
    "title": "Abbott Laboratories Dividend Stock Analysis",
    "published": 1712895240,
    "posting_price": 108.60362523,
    "close_price": 107.46115875,
    "percent_change": -1.0519598
  },
  {
    "title": "Practical Lessons From NCS Multistage Inc v. Kobold Corporation",
    "published": 1712888171,
    "posting_price": 108.60362523,
    "close_price": 107.46115875,
    "percent_change": -1.0519598
  },
  {
    "title": "Catalyst Watch: Boeing hearing, Bitcoin halving event and new eyes on Reddit",
    "published": 1712887200,
    "posting_price": 108.60362523,
    "close_price": 107.46115875,
    "percent_change": -1.0519598
  },
  {
    "title": "Medtronic's (MDT) Sphere-360 PFA Study Outcome Favorable",
    "published": 1712842260,
    "posting_price": 109.4201159,
    "close_price": 109.22410583,
    "percent_change": -0.17913532
  },
  {
    "title": "Abbott Laboratories's Dividend Analysis",
    "published": 1712833346,
    "posting_price": 109.4201159,
    "close_price": 109.22410583,
    "percent_change": -0.17913532
  },
  {
    "title": "Got $200? 2 Healthcare Stocks to Buy and Hold Forever.",
    "published": 1712830500,
    "posting_price": 109.4201159,
    "close_price": 109.22410583,
    "percent_change": -0.17913532
  },
  {
    "title": "Interesting ABT Put And Call Options For May 31st",
    "published": 1712828520,
    "posting_price": 109.4201159,
    "close_price": 109.22410583,
    "percent_change": -0.17913532
  },
  {
    "title": "DexCom Is Pricey For A Reason - Its Growth Story Reflects That",
    "published": 1712826177,
    "posting_price": 109.4201159,
    "close_price": 109.22410583,
    "percent_change": -0.17913532
  },
  {
    "title": "Abbott Laboratories Unusual Options Activity",
    "published": 1712799300,
    "posting_price": 109.4201159,
    "close_price": 109.22410583,
    "percent_change": -0.17913532
  },
  {
    "title": "7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape",
    "published": 1712769738,
    "posting_price": 108.99870379,
    "close_price": 108.9496994,
    "percent_change": -0.04495869
  },
  {
    "title": "Abbott (ABT) Rises Higher Than Market: Key Facts",
    "published": 1712699418,
    "posting_price": 108.3812784,
    "close_price": 110.19433594,
    "percent_change": 1.67285122
  },
  {
    "title": "Jim Cramer Was Upset At This Hostile Takeover, But 'They Fixed The Situation. Stock's Been A Horse'",
    "published": 1712650620,
    "posting_price": 108.3812784,
    "close_price": 110.19433594,
    "percent_change": 1.67285122
  },
  {
    "title": "Ten doctors on FDA panel reviewing Abbott heart device had financial ties with company",
    "published": 1712598650,
    "posting_price": 109.07710349,
    "close_price": 108.31267548,
    "percent_change": -0.70081436
  },
  {
    "title": "Abbott (ABT) Faces Low Testing Demand, Currency Headwinds",
    "published": 1712585400,
    "posting_price": 109.07710349,
    "close_price": 108.31267548,
    "percent_change": -0.70081436
  },
  {
    "title": "The Zacks Analyst Blog Highlights T-Mobile US, Abbott Laboratories, Palo Alto Networks, Enterprise Products Partners and The PNC Financial Services",
    "published": 1712581980,
    "posting_price": 109.07710349,
    "close_price": 108.31267548,
    "percent_change": -0.70081436
  },
  {
    "title": "Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know",
    "published": 1712581211,
    "posting_price": 109.07710349,
    "close_price": 108.31267548,
    "percent_change": -0.70081436
  },
  {
    "title": "Dividend Champion, Contender, And Challenger Highlights: Week Of April 7",
    "published": 1712394285,
    "posting_price": 109.07710349,
    "close_price": 108.31267548,
    "percent_change": -0.70081436
  },
  {
    "title": "Top Analyst Reports for T-Mobile US, Abbott Laboratories & Palo Alto Networks",
    "published": 1712350500,
    "posting_price": 107.50905366,
    "close_price": 108.97909546,
    "percent_change": 1.36736558
  },
  {
    "title": "Abbott (ABT) Receives FDA's Approval for the TriClip TEER System",
    "published": 1712325120,
    "posting_price": 107.50905366,
    "close_price": 108.97909546,
    "percent_change": 1.36736558
  },
  {
    "title": "Is It Worth Investing in Abbott (ABT) Based on Wall Street's Bullish Views?",
    "published": 1712323811,
    "posting_price": 107.50905366,
    "close_price": 108.97909546,
    "percent_change": 1.36736558
  },
  {
    "title": "BME: Trading At A Historical Discount To NAV",
    "published": 1712317631,
    "posting_price": 107.50905366,
    "close_price": 108.97909546,
    "percent_change": 1.36736558
  },
  {
    "title": "Buy Rating Reaffirmed for Abbott Labs Amid Strong Growth and New Product Launches",
    "published": 1712200140,
    "posting_price": 109.60632525,
    "close_price": 107.91088104,
    "percent_change": -1.54684888
  },
  {
    "title": "ABBOTT RECEIVES FDA APPROVAL FOR TRICLIP, FIRST-OF-ITS-KIND DEVICE TO REPAIR LEAKY TRICUSPID HEART VALVE",
    "published": 1712141384,
    "posting_price": 109.90031964,
    "close_price": 109.05749512,
    "percent_change": -0.76689906
  },
  {
    "title": "Invest with Confidence: Intrinsic Value Unveiled of Abbott Laboratories",
    "published": 1712124060,
    "posting_price": 109.90031964,
    "close_price": 109.05749512,
    "percent_change": -0.76689906
  },
  {
    "title": "Abbott price target raised by $2 at Citi, here's why",
    "published": 1712119860,
    "posting_price": 109.90031964,
    "close_price": 109.05749512,
    "percent_change": -0.76689906
  },
  {
    "title": "Abbott's (ABT) i-STAT TBI Cartridge Receives FDA Approval",
    "published": 1712071080,
    "posting_price": 109.65532154,
    "close_price": 109.78272247,
    "percent_change": 0.11618308
  },
  {
    "title": "Abbott's heart valve repair device gains US FDA approval",
    "published": 1712064989,
    "posting_price": 109.65532154,
    "close_price": 109.78272247,
    "percent_change": 0.11618308
  },
  {
    "title": "UPDATE 3-Abbott's heart valve repair device gains US FDA approval",
    "published": 1712064187,
    "posting_price": 109.65532154,
    "close_price": 109.78272247,
    "percent_change": 0.11618308
  },
  {
    "title": "Abbott Receives FDA Approval for TriClip\u2122, First-of-Its-Kind Device to Repair Leaky Tricuspid Heart Valve",
    "published": 1712062800,
    "posting_price": 109.65532154,
    "close_price": 109.78272247,
    "percent_change": 0.11618308
  },
  {
    "title": "US FDA approves Abbott's heart valve repair device",
    "published": 1712050589,
    "posting_price": 109.65532154,
    "close_price": 109.78272247,
    "percent_change": 0.11618308
  },
  {
    "title": "Abbott wins FDA approval for heart valve repair device",
    "published": 1712048700,
    "posting_price": 109.65532154,
    "close_price": 109.78272247,
    "percent_change": 0.11618308
  },
  {
    "title": "Abbott receives FDA approval for TriClip",
    "published": 1712044920,
    "posting_price": 109.65532154,
    "close_price": 109.78272247,
    "percent_change": 0.11618308
  },
  {
    "title": "Buy Rating Affirmed for Abbott Labs Following TriClip\u2019s Favorable FDA Approval and Market Outlook",
    "published": 1712037960,
    "posting_price": 109.65532154,
    "close_price": 109.78272247,
    "percent_change": 0.11618308
  },
  {
    "title": "Russell 2000 Index Best And Worst Performing Stocks Of 2024",
    "published": 1712020200,
    "posting_price": 109.65532154,
    "close_price": 109.78272247,
    "percent_change": 0.11618308
  },
  {
    "title": "PBH vs. ABT: Which Stock Is the Better Value Option?",
    "published": 1714491615,
    "posting_price": 104.91029825,
    "close_price": 104.3686142,
    "percent_change": -0.51633067
  },
  {
    "title": "7 Defensive Stocks Built to Withstand the Market\u2019s Worst Storms",
    "published": 1714471200,
    "posting_price": 104.91029825,
    "close_price": 104.3686142,
    "percent_change": -0.51633067
  },
  {
    "title": "Analysts Are Bullish on Top Healthcare Stocks: Abbott Labs (ABT), Iterum Therapeutics (ITRM)",
    "published": 1714454460,
    "posting_price": 104.91029825,
    "close_price": 104.3686142,
    "percent_change": -0.51633067
  },
  {
    "title": "Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee",
    "published": 1714395600,
    "posting_price": 105.76715323,
    "close_price": 105.64896393,
    "percent_change": -0.11174481
  },
  {
    "title": "Abbott gets FDA approval for Esprit BTK stent for PAD",
    "published": 1714381140,
    "posting_price": 105.76715323,
    "close_price": 105.64896393,
    "percent_change": -0.11174481
  },
  {
    "title": "DexCom, Insulet, Tandem seen benefitting the most in diabetes survey - Wells Fargo",
    "published": 1714379400,
    "posting_price": 105.76715323,
    "close_price": 105.64896393,
    "percent_change": -0.11174481
  },
  {
    "title": "Abbott's dissolving stent receives FDA approval for arteries below the knee",
    "published": 1714377840,
    "posting_price": 105.76715323,
    "close_price": 105.64896393,
    "percent_change": -0.11174481
  },
  {
    "title": "2 Beaten-Down Dividend Stocks to Buy and Hold Forever",
    "published": 1714304700,
    "posting_price": 105.76715323,
    "close_price": 105.64896393,
    "percent_change": -0.11174481
  },
  {
    "title": "ABT, DHR, DXCM: Which \u201cStrong Buy\u201d Healthcare Stock Has More Upside?",
    "published": 1714158562,
    "posting_price": 104.90045417,
    "close_price": 105.90503693,
    "percent_change": 0.95765339
  },
  {
    "title": "ABT July 19th Options Begin Trading",
    "published": 1714126920,
    "posting_price": 104.90045417,
    "close_price": 105.90503693,
    "percent_change": 0.95765339
  },
  {
    "title": "3 Best Healthcare Stocks to Buy in April 2024, According to Analysts",
    "published": 1714105680,
    "posting_price": 104.90045417,
    "close_price": 105.90503693,
    "percent_change": 0.95765339
  },
  {
    "title": "Intelligent Bio Solutions\u2019 Fingerprint Drug Screening Technology Poised For Massive Growth",
    "published": 1714020300,
    "posting_price": 105.03833733,
    "close_price": 105.24516296,
    "percent_change": 0.1969049
  },
  {
    "title": "Abbott Laboratories stock outperforms competitors despite losses on the day",
    "published": 1714016400,
    "posting_price": 105.03833733,
    "close_price": 105.24516296,
    "percent_change": 0.1969049
  },
  {
    "title": "Dividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes",
    "published": 1713904885,
    "posting_price": 106.04291182,
    "close_price": 105.96411896,
    "percent_change": -0.07430281
  },
  {
    "title": "It\u2019s Draft Day: Damar Hamlin Helps Build the Abbott HeartMates Team",
    "published": 1713901500,
    "posting_price": 106.04291182,
    "close_price": 105.96411896,
    "percent_change": -0.07430281
  },
  {
    "title": "It's Draft Day: Damar Hamlin Helps Build the Abbott HeartMates Team",
    "published": 1713859440,
    "posting_price": 106.04291182,
    "close_price": 105.96411896,
    "percent_change": -0.07430281
  },
  {
    "title": "Not A Millionaire? No Problem! Here's A 10-Stock Portfolio To Retire Comfortably",
    "published": 1713855620,
    "posting_price": 106.04291182,
    "close_price": 105.96411896,
    "percent_change": -0.07430281
  },
  {
    "title": "3 Best Stocks to Buy Now, 4/23/2024, According to Top Analysts",
    "published": 1713845100,
    "posting_price": 106.04291182,
    "close_price": 105.96411896,
    "percent_change": -0.07430281
  },
  {
    "title": "Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know",
    "published": 1713790811,
    "posting_price": 105.85579602,
    "close_price": 105.45198822,
    "percent_change": -0.38146971
  },
  {
    "title": "Why I Believe Abbott Is Much Better Positioned In Today's Rising Inflation Scenario",
    "published": 1713788340,
    "posting_price": 105.85579602,
    "close_price": 105.45198822,
    "percent_change": -0.38146971
  },
  {
    "title": "3 Dividend Kings Down 11% You\u2019ll Regret Not Buying on the Dip",
    "published": 1713769440,
    "posting_price": 105.85579602,
    "close_price": 105.45198822,
    "percent_change": -0.38146971
  },
  {
    "title": "Abbott price target lowered by $1 at Barclays, here's why",
    "published": 1713761400,
    "posting_price": 105.85579602,
    "close_price": 105.45198822,
    "percent_change": -0.38146971
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT) and Eli Lilly & Co (LLY)",
    "published": 1713754260,
    "posting_price": 105.85579602,
    "close_price": 105.45198822,
    "percent_change": -0.38146971
  },
  {
    "title": "Analysts Conflicted on These Healthcare Names: Terns Pharmaceuticals (TERN), Abbott Labs (ABT) and Arcutis Biotherapeutics (ARQT)",
    "published": 1713750660,
    "posting_price": 105.85579602,
    "close_price": 105.45198822,
    "percent_change": -0.38146971
  },
  {
    "title": "We Think Some Shareholders May Hesitate To Increase Abbott Laboratories' (NYSE:ABT) CEO Compensation",
    "published": 1713617079,
    "posting_price": 105.85580368,
    "close_price": 105.45199585,
    "percent_change": -0.38146971
  },
  {
    "title": "THQ: Collecting A High Yield From Increased Medical Spending",
    "published": 1713614580,
    "posting_price": 105.85580368,
    "close_price": 105.45199585,
    "percent_change": -0.38146971
  },
  {
    "title": "IGA: This 12% Yielding Global Equity CEF Now Pays Monthly",
    "published": 1713600190,
    "posting_price": 105.85580368,
    "close_price": 105.45199585,
    "percent_change": -0.38146971
  },
  {
    "title": "20 Years To $300k? Building A $10,000 Dividend Portfolio From Scratch",
    "published": 1713596400,
    "posting_price": 105.85580368,
    "close_price": 105.45199585,
    "percent_change": -0.38146971
  },
  {
    "title": "Should You Expect Accelerating Earnings Growth for Abbott Laboratories (ABT)?",
    "published": 1713534299,
    "posting_price": 104.37845568,
    "close_price": 105.65880585,
    "percent_change": 1.22664219
  },
  {
    "title": "Results: Abbott Laboratories Beat Earnings Expectations And Analysts Now Have New Forecasts",
    "published": 1713524878,
    "posting_price": 104.37845568,
    "close_price": 105.65880585,
    "percent_change": 1.22664219
  },
  {
    "title": "At least 70% of the S&P 500 names that reported results this week topped estimates - Earnings Scorecard",
    "published": 1713493500,
    "posting_price": 104.37845568,
    "close_price": 105.65880585,
    "percent_change": 1.22664219
  },
  {
    "title": "Abbott Laboratories (NYSE:ABT) Q1 2024 Earnings Call Transcript",
    "published": 1713444072,
    "posting_price": 104.89059983,
    "close_price": 103.67918396,
    "percent_change": -1.15493273
  },
  {
    "title": "Behind the Scenes of Abbott Laboratories's Latest Options Trends",
    "published": 1713443880,
    "posting_price": 104.89059983,
    "close_price": 103.67918396,
    "percent_change": -1.15493273
  },
  {
    "title": "Abbott Laboratories First Quarter 2024 Earnings: EPS Beats Expectations",
    "published": 1713438119,
    "posting_price": 104.89059983,
    "close_price": 103.67918396,
    "percent_change": -1.15493273
  },
  {
    "title": "Abbott Q1 strong but still in penalty box on litigation overhang, says Bernstein",
    "published": 1713429900,
    "posting_price": 104.89059983,
    "close_price": 103.67918396,
    "percent_change": -1.15493273
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT) and Elevance Health (ELV)",
    "published": 1713429060,
    "posting_price": 104.89059983,
    "close_price": 103.67918396,
    "percent_change": -1.15493273
  },
  {
    "title": "Abbott price target lowered by $3 at RBC Capital, here's why",
    "published": 1713428100,
    "posting_price": 104.89059983,
    "close_price": 103.67918396,
    "percent_change": -1.15493273
  },
  {
    "title": "Abbott price target lowered by $3 at Raymond James, here's why",
    "published": 1713427260,
    "posting_price": 104.89059983,
    "close_price": 103.67918396,
    "percent_change": -1.15493273
  },
  {
    "title": "Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript Highlights: Surpassing Expectations ...",
    "published": 1713423673,
    "posting_price": 104.89059983,
    "close_price": 103.67918396,
    "percent_change": -1.15493273
  },
  {
    "title": "3 Best Stocks to Buy Now, 4/18/2024, According to Top Analysts",
    "published": 1713422460,
    "posting_price": 104.89059983,
    "close_price": 103.67918396,
    "percent_change": -1.15493273
  },
  {
    "title": "5 Dividend Aristocrats Where Analysts See Capital Gains",
    "published": 1713418500,
    "posting_price": 104.89059983,
    "close_price": 103.67918396,
    "percent_change": -1.15493273
  },
  {
    "title": "Analysts Are Bullish on Top Healthcare Stocks: Abbott Labs (ABT), US Physical Therapy (USPH)",
    "published": 1713416460,
    "posting_price": 104.89059983,
    "close_price": 103.67918396,
    "percent_change": -1.15493273
  },
  {
    "title": "Buy Rating Affirmed: Abbott Labs Outperforms with Strong Q1 Sales and Upward Earnings Revision",
    "published": 1713416280,
    "posting_price": 104.89059983,
    "close_price": 103.67918396,
    "percent_change": -1.15493273
  },
  {
    "title": "Strong Q1 Performance and Growth Prospects Justify Buy Rating for Abbott Labs",
    "published": 1713416220,
    "posting_price": 104.89059983,
    "close_price": 103.67918396,
    "percent_change": -1.15493273
  },
  {
    "title": "Q1 2024 Abbott Laboratories Earnings Call",
    "published": 1713415221,
    "posting_price": 104.89059983,
    "close_price": 103.67918396,
    "percent_change": -1.15493273
  },
  {
    "title": "Abbott Undercuts Its 200-Day Line And A Flat Base Despite Its 'Solid' Quarterly Report",
    "published": 1713384667,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "U.S. Stocks Slide On Tech Weakness",
    "published": 1713384360,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript",
    "published": 1713375012,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott Labs Q1 Revenue Jumps On Strong Medical Devices Sales, Company Boosts Annual Guidance",
    "published": 1713364936,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott (ABT) Q1 Earnings Beat Estimates, Margins Contract",
    "published": 1713363180,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott Labs posts Q1 earnings beat",
    "published": 1713362564,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott Labs Stock Is Slipping After Earnings Beat. Here\u2019s Why.",
    "published": 1713362040,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott (ABT) Reports Q1 Earnings: What Key Metrics Have to Say",
    "published": 1713360607,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott Laboratories (ABT) Q1 Earnings: Surpasses EPS Estimates and Raises Full-Year Guidance",
    "published": 1713358278,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott Labs tops Q1 expectations, raises low end of 2024 guidance range",
    "published": 1713357680,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott (ABT) Tops Q1 Earnings and Revenue Estimates",
    "published": 1713357602,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "UPDATE 3-Abbott's robust medical device sales drive quarterly profit beat",
    "published": 1713355108,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott Labs Jumps, Retreats On Q1 Beat, Shy Guidance",
    "published": 1713354727,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "United jumps on earnings, stocks look to snap losing streak: Yahoo Finance",
    "published": 1713354391,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott's robust medical device sales drive quarterly profit beat",
    "published": 1713353652,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott beats quarterly profit estimates on strong medical device sales",
    "published": 1713353400,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges",
    "published": 1713353400,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Wall Street Lunch: Lilly In Limelight",
    "published": 1713353220,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "See Which Of The Latest 13F Filers Holds Abbott Laboratories",
    "published": 1713352140,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "What You Missed On Wall Street This Morning",
    "published": 1713351600,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "ABT Stock Earnings: Abbott Laboratories Beats EPS, Beats Revenue for Q1 2024",
    "published": 1713351480,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Relative Strength Alert For Abbott Laboratories",
    "published": 1713350940,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott Labs Faces Downturn Post-Q1 Results Amid Mixed Sector Performances",
    "published": 1713348900,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Stock Futures Rise as More Earnings Roll In",
    "published": 1713348900,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "ABT Makes Notable Cross Below Critical Moving Average",
    "published": 1713347700,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Dow Surges 200 Points; Abbott Laboratories Posts Upbeat Earnings",
    "published": 1713345060,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott Labs\u2019 first-quarter results top estimates amid strong medical-device sales",
    "published": 1713344700,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott says performance of business continues to be 'very strong'",
    "published": 1713344460,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "ABT Earnings: Abbott Beats Expectations with Q1 Earnings",
    "published": 1713344340,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Unusually active option classes on open April 17th",
    "published": 1713343260,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott: target ranges for 2024 tightened upwards",
    "published": 1713342438,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "5 stocks to watch on Wednesday: LLY, ABT and more",
    "published": 1713342300,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott Beats Q1 Expectations With $10 Billion In Sales, $0.98 EPS",
    "published": 1713341880,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott says broad-based growth across portfolio in Q1",
    "published": 1713341760,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Fly Intel: Pre-market Movers",
    "published": 1713340620,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott: Q1 Earnings Snapshot",
    "published": 1713339428,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott posts Q1 beat on MedTech even as diagnostics slump",
    "published": 1713339180,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott Labs first-quarter results top estimates amid strong medical device sales",
    "published": 1713338640,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Low Risk, High Return? The Power Of The 15-Stock Dividend Growth Portfolio",
    "published": 1713337200,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott in charts: Q1 sees strong results in Medical Devices and Established Pharmaceuticals",
    "published": 1713336720,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott reports Q1 worldwide COVID-19 testing sales $204M vs. $730M last year",
    "published": 1713335760,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott Laboratories Non-GAAP EPS of $0.98 beats by $0.03, raises midpoint of FY guidance ranges",
    "published": 1713335700,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott reports Q1 worldwide Medical Devices sales up 14.2% on reported basis",
    "published": 1713335700,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott sees Q2 adjusted EPS $1.08-$1.12, consensus $1.12",
    "published": 1713335580,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott revises FY24 adjusted EPS view to $4.55-$4.70 from $4.50-$4.70",
    "published": 1713335580,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott reports Q1 adjusted EPS 98c, consensus 95c",
    "published": 1713335460,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Futures inch up on megacap support; earnings, Fed comments on tap",
    "published": 1713335042,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Wall Street Poised To Rebound From Slump As Earnings Optimism Grows: Analyst Eyes This S&P 500 Level As Attractive Entry Point",
    "published": 1713334260,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Options Volatility and Implied Earnings Moves Today, April 17, 2024",
    "published": 1713333960,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott Laboratories: An Exploration into Its Intrinsic Value",
    "published": 1713333660,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott Laboratories: Organic Growth Will Be Key To Q1 Earnings",
    "published": 1713331551,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Earnings Scheduled For April 17, 2024",
    "published": 1713327300,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "What You Missed On Wall Street On Wednesday",
    "published": 1713324780,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "RBC Capital Remains a Buy on Abbott Labs (ABT)",
    "published": 1713322800,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Stocks Fall As Geopolitics, Economic Worries Spook Investors, Chipmakers Sell Off, Bitcoin Tumbles To $60,000: What's Driving Markets Wednesday?",
    "published": 1713316440,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Abbott Laboratories, U.S. Bancorp And 3 Stocks To Watch Heading Into Wednesday",
    "published": 1713316380,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "Investor Optimism Decreases; Dow Ends 6-Session Losing Streak",
    "published": 1713316380,
    "posting_price": 105.90504025,
    "close_price": 104.29967499,
    "percent_change": -1.5158535
  },
  {
    "title": "FHLC: Healthcare Dashboard For April",
    "published": 1713284682,
    "posting_price": 107.19523524,
    "close_price": 107.55964661,
    "percent_change": 0.33995109
  },
  {
    "title": "Abbott Q1 Earnings Preview: Return of core business strength could benefit top line",
    "published": 1713269580,
    "posting_price": 107.19523524,
    "close_price": 107.55964661,
    "percent_change": 0.33995109
  },
  {
    "title": "Notable companies reporting before tomorrow\u00e2\ufffd\ufffd\ufffd\ufffds open",
    "published": 1713269580,
    "posting_price": 107.19523524,
    "close_price": 107.55964661,
    "percent_change": 0.33995109
  },
  {
    "title": "Notable earnings before Wednesday's open",
    "published": 1713261660,
    "posting_price": 107.19523524,
    "close_price": 107.55964661,
    "percent_change": 0.33995109
  }
]